Sartorius Stedim Biotech's market cap is currently €20.30B. The company's EPS TTM is €1.799; its P/E ratio is 115.29; and it has a dividend yield of 0.33%. Sartorius Stedim Biotech is scheduled to report earnings on January 28, 2025, and the estimated EPS forecast is €0.92. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	€ 2.78B	€ 2.78B	€ 3.49B	€ 2.89B	€ 1.91B
Gross Profit	€ 1.21B	€ 1.23B	€ 1.83B	€ 1.55B	€ 1.00B
Operating Income	€ 370.60M	€ 484.50M	€ 995.20M	€ 683.30M	€ 471.81M
EBITDA	€ 670.50M	€ 755.70M	€ 1.35B	€ 811.96M	€ 623.79M
Net Income	€ 175.10M	€ 309.70M	€ 876.10M	€ 414.40M	€ 335.93M
Balance Sheet
Cash & Short-Term Investments	€ 688.80M	€ 126.10M	€ 133.00M	€ 237.35M	€ 69.61M
Total Assets	€ 8.26B	€ 7.74B	€ 5.07B	€ 3.95B	€ 3.07B
Total Debt	€ 2.87B	€ 3.68B	€ 1.14B	€ 625.52M	€ 586.78M
Net Debt	€ 2.19B	€ 3.57B	€ 1.03B	€ 401.89M	€ 527.02M
Total Liabilities	€ 4.23B	€ 5.07B	€ 2.55B	€ 2.22B	€ 1.59B
Stockholders' Equity	€ 3.99B	€ 2.64B	€ 2.45B	€ 1.66B	€ 1.46B
Cash Flow
Free Cash Flow	€ 475.30M	€ 156.10M	€ 181.70M	€ 371.98M	€ 257.69M
Operating Cash Flow	€ 815.10M	€ 629.70M	€ 612.30M	€ 695.97M	€ 416.88M
Investing Cash Flow	€ -340.00M	€ -2.72B	€ -957.50M	€ -465.23M	€ -621.12M
Financing Cash Flow	€ 84.90M	€ 1.99B	€ 220.70M	€ -71.71M	€ 234.07M

Currency in EUR

Sartorius Stedim Biotech Earnings and Revenue History

Income Statement >

Sartorius Stedim Biotech Debt to Assets

Balance Sheet >

Sartorius Stedim Biotech Cash Flow

Cash Flow >

Sartorius Stedim Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing